摘要:
The present invention relates to novel macrocyclic ligands substituted with at least one picolinate group, to the compounds of general formula (I), and also to the radioactive complexes thereof and to the uses thereof in medical imaging and/or in therapy, in particular in interventional radiology. The present invention also relates to a novel process for preparing the ligands according to the invention, and also to the preparation intermediates thereof. In which formula (I) Y 1 , Y 2 and Y 3 are independently a -C(O)OH group or a group of formula (II), at least one of the radicals Y 1 , Y 2 and Y 3 being a group of formula (II).
摘要:
The present invention relates to chelates resulting from the complexation of bifunctional do2pa derivatives ligands of formula (I), wherein the substituents R 1 , R 1' , R 2 , R 2' , R 3 , R 3' , L 1 , L 1' , L 2 and L 2' are defined as in the claims, with metallic cations, especially Pb(II) and Bi(III). The invention further relates to bifunctional do2pa derivatives ligands of formula (I). Another object of the invention is the use of chelates of the invention in nuclear medicine and the use of ligands of the invention in cations detection or epuration of effluents.
摘要:
The present invention relates to chelates resulting from the complexation of bifunctional do2pa derivatives ligands of formula (I), wherein the substituents R 1 , R 1' , R 2 , R 2' , R 3 , R 3' , L 1 , L 1' L 2 and L 2' are defined as in the claims, with metallic cations, especially Pb(II) and Bi(III). The invention further relates to bifunctional do2pa derivatives ligands of formula (I). Another object of the invention is the use of chelates of the invention in nuclear medicine and the use of ligands of the invention in cations detection or epuration of effluents.
摘要:
The invention relates to a chelate resulting from the complexing of a trans-di-N-picolinate tetraazacycloalkane ligand with a metal cation, said ligand corresponding to formula (A) wherein n is equal to 0 or to 1, R is H or a C1-C18 alkyl radical, and R' is H or a C1-C18 alkyl radical, said metal cation being a cation of a metal selected from the group consisting of lead (II) and bismuth (III). The invention is applicable in the field of lead trapping and alpha-radioimmunotherapy.